Javascript must be enabled to continue!
Clinically Functioning FSH-Secreting Pituitary Adenoma
View through CrossRef
Abstract
Background: Gonadotroph adenomas are the most common type of non-functioning pituitary adenomas. However functioning gonadotroph adenomas are rare with only a few cases reported in literature.
Clinical Case: A 42-year old man was admitted as a case of COVID-19 when an incidental finding of a pituitary gland mass was detected. Upon evaluation, the patient was found to have blurred vision and dizziness since few years, however no history of headache, seizures, visual field deficit were reported, nor clear symptoms related to anterior pituitary hypo- or hyperfunction. Pituitary MRI revealed a pituitary gland mass measuring 30x23x22 mm expanding the pituitary fossa and extending to suprasellar cistern. Initial laboratory investigations revealed low free T3 (1.8 pmol/L, normal: 3.1-6.8 pmol/L) and low free T4 (6.6 pmol/L, normal: 12-22 pmol/L) with normal TSH (3.54 mIU/L, normal: 0.27-4.2 mIU/L), high FSH (31.4 IU/L, normal: 1-18 IU/L), and high total testosterone (50.31 nmol/L, normal 8.3-32.9 nmol/L). Testicular ultrasound showed bilateral enlarged testicles (right testis 38.14 cm3 and left testis 33.38 cm3). Visual Field testing revealed monocular superior temporal defect affecting only the left eye. Patient was treated medically with levothyroxine and hydrocortisone and surgically by minimally invasive transsphenoidal resection of pituitary adenoma. Histopathology assessment confirmed the diagnosis of gonadotroph secreting adenoma, with positive immunostain for FSH. At 6 weeks postoperatively, insulin tolerance test was performed after which hydrocortisone was only prescribed during periods of stress. Anterior pituitary profile was repeated which revealed normalization of free T4 (14.3 pmol/L) and FSH (1.2 IU/L) and decrease in testosterone (0.66 nmol/L). Assessment of visual field revealed marked improvement of previous findings. Pituitary MRI was also repeated with findings of enhancing soft tissue remnants. At 12 weeks postoperatively, anterior pituitary profile revealed normalization of testosterone (11.3 nmol/L). Testicular ultrasound was repeated and showed a marked decrease in testicular volume (right testis 17.93 cm3 and left testis 21.13 cm3).
Conclusion: Functional gonadotroph adenomas are a rare subtype of pituitary adenomas which pose a diagnostic challenge and require meticulous clinical evaluation and multidisciplinary therapeutic approach.
The Endocrine Society
Title: Clinically Functioning FSH-Secreting Pituitary Adenoma
Description:
Abstract
Background: Gonadotroph adenomas are the most common type of non-functioning pituitary adenomas.
However functioning gonadotroph adenomas are rare with only a few cases reported in literature.
Clinical Case: A 42-year old man was admitted as a case of COVID-19 when an incidental finding of a pituitary gland mass was detected.
Upon evaluation, the patient was found to have blurred vision and dizziness since few years, however no history of headache, seizures, visual field deficit were reported, nor clear symptoms related to anterior pituitary hypo- or hyperfunction.
Pituitary MRI revealed a pituitary gland mass measuring 30x23x22 mm expanding the pituitary fossa and extending to suprasellar cistern.
Initial laboratory investigations revealed low free T3 (1.
8 pmol/L, normal: 3.
1-6.
8 pmol/L) and low free T4 (6.
6 pmol/L, normal: 12-22 pmol/L) with normal TSH (3.
54 mIU/L, normal: 0.
27-4.
2 mIU/L), high FSH (31.
4 IU/L, normal: 1-18 IU/L), and high total testosterone (50.
31 nmol/L, normal 8.
3-32.
9 nmol/L).
Testicular ultrasound showed bilateral enlarged testicles (right testis 38.
14 cm3 and left testis 33.
38 cm3).
Visual Field testing revealed monocular superior temporal defect affecting only the left eye.
Patient was treated medically with levothyroxine and hydrocortisone and surgically by minimally invasive transsphenoidal resection of pituitary adenoma.
Histopathology assessment confirmed the diagnosis of gonadotroph secreting adenoma, with positive immunostain for FSH.
At 6 weeks postoperatively, insulin tolerance test was performed after which hydrocortisone was only prescribed during periods of stress.
Anterior pituitary profile was repeated which revealed normalization of free T4 (14.
3 pmol/L) and FSH (1.
2 IU/L) and decrease in testosterone (0.
66 nmol/L).
Assessment of visual field revealed marked improvement of previous findings.
Pituitary MRI was also repeated with findings of enhancing soft tissue remnants.
At 12 weeks postoperatively, anterior pituitary profile revealed normalization of testosterone (11.
3 nmol/L).
Testicular ultrasound was repeated and showed a marked decrease in testicular volume (right testis 17.
93 cm3 and left testis 21.
13 cm3).
Conclusion: Functional gonadotroph adenomas are a rare subtype of pituitary adenomas which pose a diagnostic challenge and require meticulous clinical evaluation and multidisciplinary therapeutic approach.
Related Results
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Abstract
Introduction
Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland tumor that can lead to severe complications and carries a risk of distant metastasi...
Clinically functioning gonadotropin-secreting pituitary adenoma
Clinically functioning gonadotropin-secreting pituitary adenoma
Summary
Gonadotroph adenomas are the most common type of nonfunctional pituitary adenomas. However, functioning gonadotroph adenomas causing clinical manifestat...
Identification and gene expression profiling of human gonadotrophic pituitary adenoma stem cells
Identification and gene expression profiling of human gonadotrophic pituitary adenoma stem cells
Abstract
Background
Gonadotrophic pituitary adenoma is a major subtype of pituitary adenoma in the sellar region, but it is rarely involved in the h...
ANTIGONADOTROPHIC PROFILE OF ANTISERA AGAINST HUMAN GONADOTROPHIN PREPARATIONS
ANTIGONADOTROPHIC PROFILE OF ANTISERA AGAINST HUMAN GONADOTROPHIN PREPARATIONS
ABSTRACT
Human chorionic gonadotrophin (HCG), human menopausal gonadotrophin (HMG) and human hypophysial gonadotrophin (HHG) preparations were assayed by two bioassay metho...
BIOASSAY OF ANTIGONADOTROPHIC SERA
BIOASSAY OF ANTIGONADOTROPHIC SERA
ABSTRACT
Methods are described for the bioassay of the human follicle stimulating hormone (FSH) neutralising potency of antigonadotrophic sera. The methods are based on a m...
MON-012 The Direct Effect of Kisspeptin on Human Ovarian Granulosa Cells to Regulate Steroidogenesis
MON-012 The Direct Effect of Kisspeptin on Human Ovarian Granulosa Cells to Regulate Steroidogenesis
Abstract
Kisspeptin has a central role to stimulate the hypothalamic-pituitary-gonadal (HPG) axis. Furthermore, a previous study has suggested that kisspeptin might ...
A CASE OF PROLACTIN AND GROWTH HORMONE CO-SECRETING PITUITARY MACROADENOMA
A CASE OF PROLACTIN AND GROWTH HORMONE CO-SECRETING PITUITARY MACROADENOMA
INTRODUCTION/BACKGROUNDProlactin (PRL) and growth hormone (GH) co-secreting pituitary macroadenomas are relatively rare and exhibit a multifaceted clinical presentation. Optimal ma...
FOLLICLE STIMULATING HORMONE-LIKE ACTIVITY IN HUMAN CHORIONIC GONADOTROPHIN PREPARATIONS
FOLLICLE STIMULATING HORMONE-LIKE ACTIVITY IN HUMAN CHORIONIC GONADOTROPHIN PREPARATIONS
ABSTRACT
The follicle stimulating hormone (FSH)-like activity of human chorionic gonadotrophin (HCG) preparations was assayed by the method based on the ovarian weight augm...

